Dr. Nisha Thottam Vishnu is the best oncologist in India, specializing in radiation oncology and cancer genetics research. Currently practicing at Fortis Hospital Bangalore, she has a strong academic background, completing her M.B.B.S. from G.R. Medical College, Gwalior, and M.D. in Radiation Oncology from J.K. Cancer Institute, Kanpur. As a leading cancer specialist in Bangalore, she has gained extensive international experience, including her role as a Research Associate at the Uniformed Services University of Health Sciences (USUHS) in Bethesda, USA, where she contributed significantly to oncology research. She also collaborated with the National Institute of Health (NIH), Bethesda, focusing on Comparative Genomic Hybridization (CGH) data analysis for Hermansky Pudlak Syndrome. Recognized as a famous radiation oncologist, Dr. Nisha integrates her expertise in cancer genetics and radiation therapy to provide advanced oncology treatment in Bangalore. Her extensive contributions to the field make her a top cancer doctor at Fortis Hospital and a popular oncologist in Bangalore, offering specialized care according to individual patient needs.
Dr. Nisha Thottam Vishnu is highly skilled in radiation oncology, neurology, neurosurgery, and cancer genetics research, making her a leading oncology expert in India. Her proficiency in precision medicine in cancer allows her to develop personalized treatment plans, particularly in radiation therapy and neurosurgical oncology. With an extensive research background, she has worked at NIH, Bethesda, USA, studying genomic hybridization and genetic disorders like Hermansky Pudlak Syndrome, positioning her as a top expert in cancer genetics. Recognized as a famous oncology researcher, she integrates advanced cancer treatment in Bangalore with advanced research, ensuring the best possible outcomes for patients. Dr. Nisha’s contributions in oncology treatment at Fortis Hospital Bangalore make her a popular neurosurgical oncologist, committed to offering innovative therapies and breakthrough treatments in cancer care.